Brief: Positive Results From Pivotal Trial Of Better Therapeutics' Investigational Bt-001 Prescription Digital Therapy For Type 2 Diabetes Published In Diabetes Care
04/10/2022 12:33
Oct 4 (Reuters) - Better Therapeutics Inc BTTX.O :
* POSITIVE RESULTS FROM PIVOTAL TRIAL OF BETTER
THERAPEUTICS'
INVESTIGATIONAL BT-001 PRESCRIPTION DIGITAL THERAPY FOR TYPE 2
DIABETES PUBLISHED IN DIABETES CARE
Source text for Eikon: ID:nBw1vKn4Xa
Further company coverage: BTTX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Better Therapeutics
See all newsU.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
U.S. STOCKS ON THE MOVE-G-III Apparel Group, Tesla, MicroStrategy